Porcine Factor VIII
In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in the use of porcine factor VIII.
WFH Webinar: Treatment Options for Hemophilia in the Developing World
On December 16, 2016, the WFH in collaboration with the ISTH, recorded a live interactive webinar on the challenges and opportunities of treatment options for hemophilia in the developing world, now available for viewing here. Introduced by Marijke van den Berg, Rolf Ljung opened with a summary of the lessons learned from decades of experience […]
Pathogenic or Not? Classification of genetic variants in haemostasis
In the Wednesday morning lab sciences session on the genetic laboratory for bleeding disorders, Anne Goodeve explains the classification of genetic variants in haemostasis.
Diagnosis of von Willebrand Disease (VWD)
In the Wednesday afternoon session on von Willebrand disease (VWD) Jeroen C.J. Eikenboom explains the diagnosis of von Wilebrand Disease (VWD).
Management of Women with VWD
In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Andra H. James explains the unique issues in the management of women with von Willebrand Disease (VWD). This talk was part of the joint Laboratory Sciences and VWD Professional Development Workshop. See below for the other talks in this workshop:
Stem Cell Gene Therapy of Hemophilia A
In the Tuesday morning session on gene therapy, Christopher B. Doering presents advances in stem cell gene therapy of hemophilia A.
Genomics of Platelet Disorders
In the Wednesday morning medical plenary session, Andrew Mumford presents an overview of the genomics of platelet disorders.
Novel Assays for von Willebrand Factor (VWF) Functional Activity
In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Imre Bodó, explores new von Willebrand factor (VWF) activity assays. This talk was part of the joint Laboratory Sciences and VWD Professional Development Workshop. See below for the other talks in this workshop:
Current Management of Patients with Acquired von Willebrand Syndrome (AVWS): a 2016 update
In the Wednesday afternoon session on von Willebrand disease (VWD), Augusto B. Federici provides a 2016 update on the management of patients with acquired von Willebrand syndrome (AVWS).
Factor VII: From fundamental to bedside
In the Wednesday morning session on rare and ultra-rare bleeding disorders, Jean-François Schved discusses FVII deficiency, one of the more frequent rare bleeding disorders, from the fundamentals to the bedside.
Mechanisms of Tolerance: Immune tolerance induction
In the Monday afternoon session on alternative therapies in the management of inhibitors, David Lillicrap explores the mechanisms of tolerance that are key to immune tolerance induction.
Preventing Bleeds by Treatment: New era for hemophilia
In the Vice President Medical’s plenary of the WFH 2016 World Congress, Marijke van den Berg, discusses how bleeds may be prevented by treatment in a new era for hemophilia which she qualifies as exciting times.